Phase I/II Trial Evaluating Five Fraction SABR Dose Escalation for Early Stage Squamous Cell Carcinoma of the Lung
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: squamous cell carcinoma of the lung | lung cancer
Age: Between 18 - 100 Years
Gender: Male or Female
Pathological diagnosis of squamous cell carcinoma of the lung
Previous radiation therapy to the lung per investigator discretion
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required